Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3Gastrointestinal 3Thoracic 2Sarcoma 2Breast 2Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 481Leukemia 287Precursor Cell Lymphoblastic Leukemia-Lymphoma 249Leukemia, Lymphocytic, Chronic, B-Cell 235Myelodysplastic Syndromes 200Lymphoma 148Lymphoma, Non-Hodgkin 143Hematologic Neoplasms 138Recurrence 109Lymphoma, Mantle-Cell 102Lymphoma, Follicular 100Lymphoma, Large B-Cell, Diffuse 96Multiple Myeloma 82Leukemia, Myelogenous, Chronic, BCR-ABL Positive 81Leukemia, Myelomonocytic, Chronic 77Lymphoma, B-Cell, Marginal Zone 75Burkitt Lymphoma 72Hodgkin Disease 69Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 52Lymphoma, B-Cell 50Neoplasms 47Waldenstrom Macroglobulinemia 46Myeloproliferative Disorders 44Blast Crisis 41Lymphoma, Large-Cell, Immunoblastic 38Leukemia, Myeloid, Chronic-Phase 35Leukemia, B-Cell 34Leukemia, Myeloid, Accelerated Phase 33Congenital Abnormalities 32Leukemia, Biphenotypic, Acute 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Carcinoma, Adenoid Cystic × Other hematologic neoplasm × Clear all
NCT03422679 2024-01-16

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Cellestia Biotech AG

Phase 1/2 Terminated
79 enrolled 22 charts
BreastGastrointestinalLymphoidOther hematologic neoplasmSarcoma

Breast Neoplasms, Carcinoma, Adenoid Cystic, Glomus Tumor, Carcinoma, Hepatocellular, Lymphoma, Non-Hodgkin, Osteosarcoma, Colorectal Neoplasms, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡